PharmaGap Home Contact Us
top line
sepsepDiscovery EnginesepsepPartnering
1

Archive 2007

11.21.07 PharmaGap Issues New Series 4 Notes
10.15.07 PharmaGap Reaches Agreement with Debenture Holder to extend Maturity Date
09.19.07 PharmaGap Agreement with Debenture Holders to extend Maturity Date to be modified to comply with TSX-V Regulations
08.31.07 PharmaGap Reaches Agreement with Debenture Holders to extend Maturity Date
08.07.07 PharmaGap Announces Option Grants to Officers and Directors
07.04.07 Board of Directors Change
06.14.07 PharmaGap Completes Sale of Equity Units
06.04.07 PharmaGap Annual Meeting on July 31
05.29.07 PharmaGap Reports Improved Efficacy of Cancer Drug Compound in Queen's University Study
05.16.07 PharmaGap Announces Results of Testing at Memorial Sloan-Kettering Cancer Center in New York
05.07.07 PharmaGap Receives TSX-V Approval for $550,000 Investment by Dundee Securities; Sale of $1.95 million in Shares and Warrants to Accredited Investors Initiated
05.03.07 PharmaGap Announces $550,000 Investment by Dundee Securities Corporation; Additional Amounts to be offered for Public Purchase

Archives

Press Releases on SEDAR

Past Releases  2005 | 2006 | 2007


To receive PharmaGap press releases by email please send us an electronic request (click here)
Scientist

Web Media
CTV - NEW DRUG AGAINST CANCER
footer